by David Kent | Mar 22, 2011
I recently attended a special conference on Stem Cells, Development, and Cancer run by the American Association for Cancer Research (AACR) where Connie Eaves from the British Columbia Cancer Agency chaired a session entitled “Emerging Technologies” and said something...
by Ubaka Ogbogu | Mar 17, 2011
The Australian government is currently reviewing their stem cell and cloning research laws. The review, which began on December 22, 2010 with the appointment of an independent Legislation Review Committee (LRC) chaired by a retired federal judge, is the second since...
by Stem Cell Network | Mar 15, 2011
Yesterday the Ministers of Health for the Provinces and Territories of Canada announced an investment of CAD $48M over eight years to establish a national umbilical cord blood bank for Canada. This is a very welcome, and some might say, overdue investment for which...
by Paul Krzyzanowski | Mar 9, 2011
Patenting report shows disconnect in Canada by Paul Krzyzanowski Got a patentable idea? You might want to move to Switzerland. A recent article in the Globe and Mail compared Canada’s patenting activity to other major countries, and the small European nation...
by Stem Cell Network | Mar 7, 2011
What role does art play in communicating science? It’s a question that has been asked and studied rather extensively and it was one of the topics raised during the POP/SCIENCE panel discussion at the Glenbow Museum in Calgary last Thursday. The event was held in...
by Stem Cell Network | Mar 3, 2011
I’ve heard many different adjectives used to frame discussions of stem cells: powerful, promising, controversial, cutting edge, rejuvenating, mysterious, sexy, to name but a few. All of these descriptors are used in various ways to promote particular opinions,...
by Chris Kamel | Mar 2, 2011
They’re promising, but not perfect. Induced pluripotent stem cells are perhaps one of the most studied areas of stem cell research today, as researchers work to improve their method of production, but new findings out of Canada and Finland suggests that the...
by Chris Kamel | Feb 28, 2011
We’ve talked often about induced pluripotent stem cells (iPS cells) on this blog — the transformation of adult terminally differentiated cells into stem cells that can differentiate into various lineages — mostly in the context of discoveries in mice...
by Michelle Ly | Feb 22, 2011
As we get further into 2011, embryonic stem (ES) cells continue to be a hot topic. The ability of ES cells to differentiate into virtually any other type of cell makes them a prime avenue for research in biomedical applications. They have also been a source of great...
by Michelle Ly | Feb 14, 2011
In previous posts, I discussed the use of cell therapy, specifically the application of allogenic or autologous hematopoietic stem cells (HSCs), as a way to repopulate blood cell lineages to normal levels post-treatment in patients suffering from certain types of...
Comments